sq-11725 has been researched along with Lassitude in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, JC; Christie, MH; Fand, RS; Shafer, WB; Vernam, KA | 1 |
| DiBianco, R; Fletcher, R; Katz, RJ; Park, J; Shapiro, W; Singh, SN | 1 |
2 trial(s) available for sq-11725 and Lassitude
| Article | Year |
|---|---|
Long-term experience with nadolol in treatment of hypertension and angina pectoris.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Blood Pressure; Blood Urea Nitrogen; Clinical Trials as Topic; Creatinine; Diuretics; Dizziness; Drug Therapy, Combination; Erectile Dysfunction; Fatigue; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nadolol; Propanolamines; Respiratory Sounds; Sleep Stages; Time Factors | 1984 |
Comparison of nadolol, a new long-acting beta-receptor blocking agent, and placebo in the treatment of stable angina pectoris.
Topics: Angina Pectoris; Bradycardia; Clinical Trials as Topic; Exercise Test; Fatigue; Humans; Hypotension; Male; Nadolol; Nitroglycerin; Placebos; Propanolamines | 1981 |